Showing 1 - 7 of 7
Persistent link: https://www.econbiz.de/10002374960
Persistent link: https://www.econbiz.de/10003715781
The subject of the paper is financial valuation of firm's knowledge assets and returns to innovation in the biotechnology industry, where such assets appear to play key role in the commercial success of a product. The biotechnology industry is extremely research-intensive, and successful R&D...
Persistent link: https://www.econbiz.de/10005446482
Persistent link: https://www.econbiz.de/10010258391
We explore the relation between antitakeover provisions (i.e. managerial entrenchment) and firm performance in innovation. Empirical results indicate that an increase in antitakeover provisions is negatively related to number of patents and number of citations to patents. Thus managers who are...
Persistent link: https://www.econbiz.de/10013060331
The U.S. Orphan Drug Act provides R&D incentives to drug-makers that go beyond statutory patent protection. The study explores the act's effect on financial returns to innovation and on the strategy of orphan drug development. Results indicate that the financial return to orphan drug development...
Persistent link: https://www.econbiz.de/10014149586
The subject of the paper is financial valuation of firm's knowledge assets and returns to innovation in the biotechnology industry, where such assets appear to play key role in the commercial success of a product. The biotechnology industry is extremely research-intensive, and successful R&D...
Persistent link: https://www.econbiz.de/10014149587